“Maximum Tolerated Dose” Versus “Fixed Low-Dose” Hydroxyurea for Treatment of Adults With Sickle Cell Anemia
American Journal of Hematology - United States
doi 10.1002/ajh.25412
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 6, 2019
Authors
Publisher
Wiley